Cardio Diagnostics Showcases AI Solutions at Four June Benefits Conferences
CDIO•Cardio Diagnostics will exhibit its AI-powered cardiovascular risk solutions at four national benefits conferences in June, targeting employers, brokers, union trustees and plan administrators. The showcased offerings, Epi+Gen CHD, PrecisionCHD and the HeartRisk platform, aim to identify at-risk individuals earlier and help manage health plan costs and workforce productivity.
1. Conference Participation
Cardio Diagnostics will exhibit at four national benefits conferences in June, engaging employers, brokers, union trustees and plan administrators. The events offer direct access to decision-makers overseeing health plan strategies and workforce wellness initiatives.
2. AI-Powered Solutions Showcase
The company will showcase AI-powered solutions including Epi+Gen CHD for genetic-epigenetic coronary risk assessment, PrecisionCHD for personalized heart disease profiling and the HeartRisk platform for population-level insights. Each offering leverages a proprietary AI-driven integrated genetic-epigenetic engine to identify at-risk individuals earlier.
3. Strategic Objectives
By demonstrating these tools, Cardio Diagnostics aims to help benefits decision-makers better manage healthcare costs and improve workforce productivity. Early risk identification through AI-driven assessments can reduce treatment expenses and enhance preventive care outcomes for employer-sponsored health plans.
